AKT1 and cancer: Pharmacogenomic and &lt;i&gt;in silico&lt;/i&gt; identification of isoform-selective AKT inhibitors from &lt;i&gt;Pithecellobium dulce&lt;/i&gt; for precision cancer therapy.